Celldex Therapeutics, Inc. (CLDX) short interest & options flow
NASDAQCLDX fell 5.5% on Thursday to $28.27, extending a 13% decline over the past month, while short interest holds at 14.5% of the free float, roughly 9.6 million shares, a level that has barely moved despite the stock's slide. That gap between price action and short positioning is the key tension heading into Monday's earnings release. The short position has been drifting lower very…
- Market cap
- $2.37B
- Next earnings
- 22 Feb 2027
Key data as of 12 Nov 2026

CLDX news and analysis
RSSNo long-form analysis yet for CLDX. Pulse alerts and the live data picture are available on ORTEX.
Open CLDX on ORTEX →Want the live picture for CLDX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CLDX — free to start on ORTEX.
Sign up for free →Open CLDX on ORTEX